А. L. Maslyanskiy

Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study

Evgeniy Nasonov, Saeed Fatenejad, Eugen Feist et al. · Annals of the Rheumatic Diseases · 2021 · 67 citations · Full text

Treatment of Idiopathic Recurrent Pericarditis With Goflikicept

V. Yu. Myachikova, А. L. Maslyanskiy, Oksana V. Vinogradova et al. · Journal of the American College of Cardiology · 2023 · 60 citations

Idiopathic Recurrent Pericarditis, Pericardial Disease, Constrictive Pericarditis +3

Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis

Luisa Lindenberg, Lydia Spengler, Holger Bang et al. · Arthritis Research & Therapy · 2015 · 14 citations · Full text

Idiopathic recurrent pericarditis – a new orphan autoinflammatory disease? A retrospective analysis of cases of idiopathic recurrent pericarditis and a design of а double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of RPH-104 treatment in patients with idiopathic recurrent pericarditis

V. Yu. Myachikova, А. L. Maslyanskiy · Kardiologiia · 2021 · 12 citations · Full text

Effectiveness and safety of BCD180, anti-TRBV9<sup>+</sup> T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTA

Mazurov Vi, I. Z. Gaydukova, S. Lapshina et al. · Rheumatology Science and Practice · 2024 · 12 citations · Full text